Orem, UT, and Nijmegen, Netherlands — March 20, 2025 — Techcyte, a leader in digital pathology and Aiosyn, a leading developer of AI-driven pathology algorithms, today announced a collaboration that brings Aisoyn’s AI algorithms to the...

The shift towards digital pathology has marked a significant advancement in breast cancer diagnosis. High-resolution digital imaging of slides provides pathologists with an unprecedentedly clear and expansive view of tissue samples for their...

Gestalt: Algorithm designed to save time for pathologists Gestalt Diagnostics LLC has launched an artificial intelligence-assisted algorithm that can be used to aid pathologists in grading and classifying eight types of cancers through...

Gestalt Diagnostics: Algorithm for Use on Eight Types of Cancer Trained on Seven Scanner Models SPOKANE, Wash., Sept. 19, 2023 /PRNewswire/ -- Gestalt Diagnostics is proud to announce our latest release – an AI algorithm for use on one of...